GlassScriptPhysician profile
Pradeep Bollu
NPI 1598094393
$51,957.03
in general payments reported to CMS, 2019-2025
20 companies · $8,060 in 2025
The $8,060 reported for 2025 was more than what 88% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.71 · 2020: $29.76 · 2021: $502 · 2022: $15K · 2023: $28K · 2024: $145 · 2025: $8,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $2,480 · Food and Beverage: $1,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,345.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,050.00 |
| Travel and Lodging | $2,480.14 |
| Food and Beverage | $1,060.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $16,704.82 | 2022-2025 | Qulipta, Ubrelvy, Botox |
| Kyowa Kirin, INC. | $10,819.58 | 2022-2023 | Nourianz |
| Biohaven Pharmaceutical Holding Company LTD. | $10,361.62 | 2022 | |
| Pfizer INC. | $7,697.72 | 2025 | |
| Impel Pharmaceuticals INC. | $4,369.20 | 2022-2023 | Trudhesa |
| Medtronic, INC. | $671.02 | 2022 | |
| Allergan, INC. | $413.01 | 2021 | |
| Boston Scientific Corporation | $194.73 | 2025 | Vercise |
| Genzyme Corporation | $132.63 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $111.45 | 2022 | |
| Abbott Laboratories | $109.94 | 2021-2022 | |
| Imperative Care, INC | $107.73 | 2024 | Zoom 88-T Large Distal Platform |
| Emd Serono, INC. | $75.71 | 2019 | |
| Tg Therapeutics, INC. | $48.70 | 2025 | |
| Grifols USA, LLC | $31.04 | 2025 | Gamunex-C |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $29.76 | 2020 | |
| Sk Life Science, INC. | $28.25 | 2025 | |
| Argenx US, INC. | $27.98 | 2025 | Vyvgart |
| Mdd US Operations, LLC | $22.14 | 2024 | Gocovri |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pradeep Bollu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.